Patenting activity in drugs for renal disease, January 2002 - June 2004

Bibliography

• LIT, SURENDRAN K, ZAWAIDEH MA,MATHEW S, HRUSKA KA: Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease.Corr. Opin. Nephrol. Hypertens. (2004) 13:417–422.
   PubMed Web of Science ®Google Scholar
• MAISCH NM, PEZZILLO KK: HMG-CoA reductase inhibitors for the prevention of nephropathy. Ann. Pharmacother. (2004) 38:342–345.
   PubMed Web of Science ®Google Scholar
• LITCHFIELD DW: Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem..1. (2003) 369:1–15.
   PubMed Web of Science ®Google Scholar
• AHOLA H, HEIKKILA E, ASTROM E et al: A novel protein, densin, expressed by glomerular podocytes. I. Am. Soc. Nephrol. (2003) 14:1731–1737.
   PubMed Web of Science ®Google Scholar
• EDDY AA: Molecular basis of renal fibrosis. Pediatr. Nephrol. (2000) 15:290–301.
   PubMed Web of Science ®Google Scholar
• LAPING NJ: ALK5 inhibition in renal disease. Curr. Opin. Pharinacol (2003) 3:204–208.
   PubMed Web of Science ®Google Scholar
• DACOSTA BS, MAJOR C, LAPING NJ, ROBERTS AB: SB-505124 is a selective inhibitor of transforming growth factor-I3 Type I receptors ALK4, ALK5, and ALK7. Mol. Pharinacol (2004) 65:744–752.
   PubMed Web of Science ®Google Scholar
• ANDERS HJ, VIELHAUER V, FRINK M et al.: A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. (2002) 109:251–259.
   PubMed Web of Science ®Google Scholar
• ALDERSON NL, CHACHICH ME, YOUSSEF NN et al: The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney mt. (2003) 63:2123–2133.
   PubMed Web of Science ®Google Scholar
• ANDERSON RJ: Recent advances and developments in the treatment of acute renal failure. Expert Opin. Ther. Patents (2002) 12:645–655.
   Web of Science ®Google Scholar
• HEIDEMANN HT, MULLER S, MERTINS L, STEPAN G, HOFFMANN K, OHNHAUS EE: Effect of aminophylline on cisplatin nephrotoxicity in the rat. Br. J. Pharmacol (1989) 97:313–318.
   PubMed Web of Science ®Google Scholar
• BIDANI AK, CHURCHILL PC: Aminophylline ameliorates glycerol-induced acute renal failure in rats. Can. Physiol Pharinacol (1983) 61:567–571.
   PubMed Web of Science ®Google Scholar
• LEAKEY TE, ELIAS-JONES AC, COATES PE, SMITH KJ: Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case report. Clin. Pharmacokinet. (1991) 21:400–408.
   PubMed Web of Science ®Google Scholar
• SALOM MG, RAMIREZ P, CARBONELL LF et al: Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion. Transplantation (1998) 65:1315–1321.
   PubMed Web of Science ®Google Scholar
• SHEIKH-HAMAD D, TIMMINS K, JALALI Z: Cisplatin-induced renal toxicity:possible reversal by N-acetylcysteine treatment. I Am. Soc. Nephrol (1997) 8:1640–1644.
   PubMed Web of Science ®Google Scholar
• VINCENTI F: What's in the pipeline? Newimmunosuppressive drugs in transplantation. Am. J. Transplant (2002) 2:898–903.
   PubMed Web of Science ®Google Scholar
• MATSUNAMI K, MIYAGAWA S, YAMADA M, YOSHITATSU M, SHIRAKURA R: A surface-bound form of human Cl esterase inhibitor improves xenograft rejection. Transplantation (2000) 69:749–755.
   PubMed Web of Science ®Google Scholar
• MURAI M, OYA M: Renal cell carcinoma:etiology, incidence and epidemiology. Curr. Opin. LIM. (2004) 14:229–233.
   Google Scholar
• UEMURA H, NAKAGAWA Y, YOSHIDA K et at. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. BE J. Cancer (1999) 81:741–746.
   Google Scholar
• BUI MH, VISAPAA H, SELIGSON D et al. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. J. Um]. (2004) 171:2461–2466.
   Google Scholar
• VISSERS JL, DE V I, SCHREURS MW et al.: The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes. Cancer Res. (1999) 59:5554–5559.
   Google Scholar
• IWAMURA M, WU W, MURAMOTO M et al.: Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma. Cancer(1999) 86:1028–1034.
   PubMed Web of Science ®Google Scholar
• MASSFELDER T, LANG H, SCHORDAN E et al.: Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res. (2004) 64:180–188.
   PubMed Web of Science ®Google Scholar
• RAE FK, HOOPER JD, EYRE HJ, SUTHERLAND GR, NICOL DL, CLEMENTS JA: TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinoma. Genomics (2001) 77:200–207.
   PubMed Web of Science ®Google Scholar
• WANG D, IVERSEN J, WILCOX CS, STRANDGAARD S: Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int. (2003) 64:1381–1388.
   PubMed Web of Science ®Google Scholar
• PERSU A, STOENOIU MS, MESSIAEN T et al.: Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum. Mol. Genet. (2002) 11:229–241.
   PubMed Web of Science ®Google Scholar
• DELL KM, NEMO R, SWEENEY WE JR,LEVIN JI, FROST P, AVNER ED: A novel inhibitor of tumor necrosis factor-a converting enzyme ameliorates polycystic kidney disease. Kidney Int. (2001) 60:1240–1248.
   PubMed Web of Science ®Google Scholar
• OBRADOR GT, PEREIRA BJ, KAUSZ AT: Chronic kidney disease in the United States: an underrecognized problem. Semi]. Nephrof (2002) 22:441–448.
   PubMed Web of Science ®Google Scholar
• VINCENTI F: A decade of progress in kidney transplantation. Transplantation (2004) 77:S52–S61.
   Web of Science ®Google Scholar
• DEVARAJAN P, MISHRA J, SUPAVEKIN S, PATTERSON LT, STEVEN PS: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol. Genet. Metab (2003) 80:365–376.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI M, SUGIMURA J, YANG X et al.: Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv.Cancer Res. (2003) 89:157–81.
   PubMed Web of Science ®Google Scholar
• CHUA MS, MANSFIELD E, SARWAL M:Applications of microarrays to renal transplantation:progress and possibilities. Front Biosci. (2003) 8:s913–s923.
   Google Scholar